[NO and hypertension].
Hirata
Yasunobu
Y
Department of Cardiovascular Medicine, University of Tokyo.
D000804:Angiotensin II / Q000502:physiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D001120:Arginine / Q000031:analogs & derivatives* / Q000502:physiology; D001161:Arteriosclerosis / Q000209:etiology / Q000503:physiopathology; D001708:Biopterins / Q000031:analogs & derivatives* / Q000502:physiology; D002097:C-Reactive Protein / Q000502:physiology; D004730:Endothelium, Vascular / Q000378:metabolism / Q000502:physiology* / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D009154:Mutation; D019255:NADPH Oxidases / Q000502:physiology; D009569:Nitric Oxide / Q000378:metabolism / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000235:genetics; D052250:Nitric Oxide Synthase Type III; D020913:Perindopril / Q000494:pharmacology / Q000627:therapeutic use; D017382:Reactive Oxygen Species / Q000378:metabolism; D014664:Vasodilation / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D017382:Reactive Oxygen Species; D000804:Angiotensin II; D001708:Biopterins; D009569:Nitric Oxide; C018524:N,N-dimethylarginine; D002097:C-Reactive Protein; D001120:Arginine; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D019255:NADPH Oxidases; C003402:sapropterin; D020913:Perindopril